Figures & data
Table 1 Summary of the use of three different formulations of triamcinolone acetonide (TA) and the rates of sterile endophthalmitis (SE) with each formulation
Table 2 Pre- and postdiagnosis data on patients with sterile endophthalmitis following intravitreal triamcinolone acetonide
Figure 1 Representative images of particles of Triesence® (A, C) and Kenalog®-40 (B, D). In (A and B), samples were diluted in buffered salt solution. In (C and D), samples were diluted in a solution containing 1 g/L Triton X-100. Samples were photographed with a Nikon Labophot polarizing light microscope with Clemex Vision Lite 4.0 software. Images were taken at a magnification of 400×.
Figure 2 Distributions of particle sizes of Kenalog®-40 (A, B), Triesence® (C, D). Mean diameter of each formulation was determined using a Model 700 Accusizer on a volume-weighted basis. Each bar represents the percentage of all particles of the formulation which were of the corresponding diameter indicated on the x-axis.
Table 3 Particle analyses of different formulations of triamcinolone acetonide